Glatiramer acetate and treatment of multiple sclerosis

Abstract

The 2010 revised McDonald criteria reflect the clinical requirement to establish the diagnosis of multiple sclerosis (MS) as early as the initial attack of neurological symptoms, in an early stage-that of clinically isolated syndrome (CIS).

Keywords

• clinically isolated syndrome
• multiple sclerosis
• McDonald criteria
• magnetic resonance imaging
• glatimer acetate